Literature DB >> 20398617

Changing epidemiology of invasive Haemophilus influenzae in Ontario, Canada: evidence for herd effects and strain replacement due to Hib vaccination.

H J Adam1, S E Richardson, F B Jamieson, P Rawte, D E Low, D N Fisman.   

Abstract

The epidemiology of invasive Haemophilus influenzae infections was evaluated in Ontario between 1989 and 2007 to assess the impact of the introduction of the conjugate H. influenzae serotype b (Hib) vaccine in the early 1990 s on Hib and non-Hib serotypes in both vaccinated and unvaccinated cohorts as well as the possibility of "strain replacement" with non-vaccine H. influenzae strains. Data were collected by the provincial Public Health Laboratories-Toronto, Ontario Agency for Health Protection and Promotion, which performed almost all serotyping on invasive (blood, CSF, other sterile sites) H. influenzae strains isolated in the province during the study period. Temporal trends for Hib, other typeable strains, and non-typeable H. influenzae were evaluated by Poisson regression, controlling for the specimen submissions. Prior to infant Hib vaccination, the most commonly observed serotype was serotype b (64.9%). Subsequently, 70.3%, 13.6%, and 9.4% of isolates were non-typeable, serotype f, and serotype b, respectively. Infant Hib vaccination resulted in a decrease in Hib incidence in all age groups (pooled IRR 0.432) and marked increases of non-typeable and serotype f H. influenzae in children aged <5 years (IRR 2.4 and 3.0, respectively). Vaccination against Hib has altered the epidemiology of invasive H. influenzae infections in Ontario. Prevention of invasive Hib disease was observed in both vaccinated and unvaccinated age groups. Invasive H. influenzae infection now commonly presents as sepsis due to non-typeable H. influenzae in older individuals. However, strain replacement of Hib with serotype f and non-typeable strains in children under 5 years was documented. (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20398617     DOI: 10.1016/j.vaccine.2010.03.075

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  51 in total

Review 1.  Valuing vaccination.

Authors:  Till Bärnighausen; David E Bloom; Elizabeth T Cafiero-Fonseca; Jennifer Carroll O'Brien
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-18       Impact factor: 11.205

2.  Emergence of non-serotype b encapsulated Haemophilus influenzae as a cause of pediatric meningitis in northwestern Ontario.

Authors:  Pouya Sadeghi-Aval; Raymond Sw Tsang; Frances B Jamieson; Marina Ulanova
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

Review 3.  The role of vaccines in preventing bacterial antimicrobial resistance.

Authors:  Kathrin U Jansen; Charles Knirsch; Annaliesa S Anderson
Journal:  Nat Med       Date:  2018-01-09       Impact factor: 53.440

4.  Risk of invasive Haemophilus influenzae type b (Hib) disease in adults with secondary immunodeficiency in the post-Hib vaccine era.

Authors:  Eli B Nix; Nicole Hawdon; Sean Gravelle; Birubi Biman; Malcolm Brigden; Saleem Malik; William McCready; Garry Ferroni; Marina Ulanova
Journal:  Clin Vaccine Immunol       Date:  2012-03-07

5.  Antibiotic susceptibility and molecular analysis of invasive Haemophilus influenzae in Canada, 2007 to 2014.

Authors:  Raymond S W Tsang; Michelle Shuel; Kathleen Whyte; Linda Hoang; Gregory Tyrrell; Greg Horsman; John Wylie; Frances Jamieson; Brigitte Lefebvre; David Haldane; Rita R Gad; Gregory J German; Robert Needle
Journal:  J Antimicrob Chemother       Date:  2017-05-01       Impact factor: 5.790

6.  Evidence for cross-protection but not type-replacement over the 11 years after human papillomavirus vaccine introduction.

Authors:  Courtney Covert; Lili Ding; Darron Brown; Eduardo L Franco; David I Bernstein; Jessica A Kahn
Journal:  Hum Vaccin Immunother       Date:  2019-02-20       Impact factor: 3.452

Review 7.  Population-based epidemiology and microbiology of community-onset bloodstream infections.

Authors:  Kevin B Laupland; Deirdre L Church
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

8.  Why we need a vaccine for non-typeable Haemophilus influenzae.

Authors:  Marina Cerquetti; Maria Giufrè
Journal:  Hum Vaccin Immunother       Date:  2016-05-12       Impact factor: 3.452

9.  Adhesin genes and serum resistance in Haemophilus influenzae type f isolates.

Authors:  Michael E Watson; Kevin L Nelson; Victoria Nguyen; Carey-Ann D Burnham; Jill E Clarridge; Xuan Qin; Arnold L Smith
Journal:  J Med Microbiol       Date:  2012-12-14       Impact factor: 2.472

10.  Invasive Haemophilus influenzae in the United States, 1999-2008: epidemiology and outcomes.

Authors:  Daniel J Livorsi; Jessica R Macneil; Amanda C Cohn; Joseph Bareta; Shelly Zansky; Susan Petit; Ken Gershman; Lee H Harrison; Ruth Lynfield; Arthur Reingold; William Schaffner; Ann Thomas; Monica M Farley
Journal:  J Infect       Date:  2012-08-15       Impact factor: 6.072

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.